Welcome to our dedicated page for RLI SEC filings (Ticker: RLI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The RLI Corp. (NYSE: RLI) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a specialty insurer in niche property, casualty and surety markets. RLI files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, along with other required documents under U.S. securities laws.
Through these filings, investors can review segment performance for RLI’s Casualty, Property and Surety operations, including net premiums earned, loss and settlement expenses, policy acquisition costs, insurance operating expenses and underwriting income. Management also explains non-GAAP measures such as operating earnings and operating earnings per share, reconciling them to GAAP net earnings and detailing the impact of realized and unrealized investment gains and losses.
RLI’s Form 8-K filings frequently report quarterly results, dividend declarations and leadership changes. Examples include announcements of regular and special cash dividends, conference call transcripts discussing financial results, and executive transitions in roles such as Chief Financial Officer. These current reports give timely insight into material events affecting the company’s capital management and governance.
Filings also disclose the company’s corporate structure and securities information, noting that RLI is incorporated in Delaware and that its common stock is listed on the New York Stock Exchange under the symbol RLI. Investors can use the filings to understand RLI’s long record of underwriting profits and its approach to reserve development, catastrophe losses and investment portfolio management.
On Stock Titan, RLI filings are updated in near real time from the SEC’s EDGAR system. AI-powered summaries help explain lengthy 10-K and 10-Q reports, highlight key trends in underwriting and investment performance, and clarify the significance of 8-K items such as dividend actions or executive appointments. Users can also quickly locate information related to compensation programs and incentive plans described in governance-related filings.
This page is a practical starting point for anyone analyzing RLI’s specialty insurance business, financial condition and risk profile through its official SEC disclosures.
RLI Corp reported an insider transaction on a Form 4. A director received an allocation of 445.217 shares of common stock at $58.96 on 10/31/2025 (transaction code J). The holdings are reported as indirect through a Directors' Trust, bringing the amount beneficially owned after the transaction to 6,172.425 shares.
The filing notes the shares were allocated under the RLI Corp. Non-Employee Directors Deferred Compensation Plan, with figures adjusted for a 2-for-1 stock split on 01/15/25, and the balance reflects dividend reinvestment.
RLI Corp (RLI) reported an insider transaction by a director. On 10/31/2025, the reporting person recorded an indirect acquisition of 121.905 shares of common stock at $58.96 per share (transaction code J), allocated pursuant to the RLI Corp. Non-Employee Directors Deferred Compensation Plan. Following the transaction, beneficial ownership stood at 19,732.393 shares held indirectly via a Directors' Trust. The filing notes amounts were adjusted for a 2-for-1 stock split on 01/15/25 and that ownership reflects dividend reinvestment.
RLI Corp. filed an 8-K announcing it held an analyst conference call regarding its third quarter 2025 results on October 21, 2025. The company furnished the call transcript as Exhibit 99.1, which is incorporated by reference.
The filing states that furnishing the transcript is not intended to indicate it is required under Regulation FD or that it contains material investor information beyond what is publicly available. The company also notes it does not assume an obligation to update the information.
RLI Corp. reported stronger Q3 2025 results. Consolidated revenue reached $509.3 million (up from $470.0 million), driven by higher net premiums earned of $407.7 million and net investment income of $41.3 million. Net earnings rose to $124.6 million with diluted EPS of $1.35, helped by $18.3 million of realized gains and $42.0 million of unrealized gains on equity securities.
Total expenses were $353.6 million as loss costs declined year over year. For the first nine months, net earnings were $312.2 million and operating cash flow was $457.5 million. Prior-year reserve development was favorable by $74 million year to date, notably in commercial excess liability, marine, surety, commercial property, general liability and mortgage reinsurance; commercial transportation experienced adverse auto liability development.
On the balance sheet, total assets were $6.25 billion and shareholders’ equity was $1.87 billion. The available-for-sale fixed income portfolio was $3.54 billion at fair value, and equity securities were $878.9 million. The company effected a two-for-one stock split on January 15, 2025. Shares outstanding were 91,837,835 as of October 14, 2025.
RLI Corp. filed a Form 8-K stating it announced results of operations for the third quarter of 2025. The company furnished a press release as Exhibit 99.1 under Item 2.02, which is incorporated by reference.
The press release provides the detailed financial results; this exhibit is furnished and not deemed filed under the Exchange Act.
Seth A. Davis, Vice President and Controller of RLI Corp (RLI), acquired 1,250 stock options on 08/01/2025 with an exercise price of $65.89. The options are exercisable beginning 08/01/2026 and expire on 08/01/2033. The reported grant increases his direct beneficial ownership of derivative securities to 1,250 options and is recorded with transaction code A (acquisition).
The grant vests in five annual tranches of 20% starting one year after the grant date, per the attached option schedule. The Form shows a reported derivative price of $0, and no cash purchase is reported on the form. This disclosure documents a routine executive compensation award with multi-year vesting terms.